a developer of biomedical research products in the field of stem cells and regenerative medicine
Industry Biotechnology
A.I.dvisor tells us that ERNA and ALRN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERNA and ALRN's prices will move in lockstep.
Ticker / NAME | Correlation To ERNA | 1D Price Change % | ||
---|---|---|---|---|
ERNA | 100% | -3.61% | ||
ALRN - ERNA | 29% Poorly correlated | -9.43% | ||
LXRX - ERNA | 27% Poorly correlated | -4.64% | ||
ADCT - ERNA | 26% Poorly correlated | +6.50% | ||
MLYS - ERNA | 25% Poorly correlated | +1.56% | ||
VSTM - ERNA | 25% Poorly correlated | -1.71% | ||
More |